Dr. Douglas J. Navasartian, MD

Dr. Navasartian practices at Orthopaedic Sports Medicine and Rehabilitation Center in Red Bank, New Jersey.

Dr. Navasartian's NPI, 1356780944, was assigned on June 18, 2013. Dr. Navasartian graduated from Renaissance School of Medicine at Stony Brook University in 2013. Dr. Navasartian holds California license A160456.

Dr. Navasartian's primary practice is Orthopaedic Sports Medicine and Rehabilitation Center, at 80 Oak Hill Rd, Red Bank, NJ 07701 in Monmouth County. The practice phone is (732) 741-2313.

Dr. Navasartian's primary practice is Orthopaedic Sports Medicine and Rehabilitation Center in Red Bank, New Jersey. Dr. Navasartian is also affiliated with Riverview Medical Center. The medical group on file is OrthoCenter. Dmand AI also links Dr. Navasartian to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Navasartian practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Navasartian's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Navasartian is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Navasartian's licenses on file in 5 states: California, New Jersey, Texas, Illinois and Pennsylvania.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, hand joint or tendon inflammation, joint pain and knee fracture and dislocation among the conditions Dr. Navasartian treats.

CMS data shows 2,578 Medicare services from Dr. Navasartian across 19 procedure codes in 2024, for 379 Medicare patients. Medicare paid $96,787 for them.

CMS counts 379 Medicare patients who saw Dr. Navasartian in 2024. The largest group is 65 to 74, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Navasartian's median patient age at 63, with 52% women.

In 2024, Dr. Navasartian wrote 104 Medicare Part D claims for 73 patients. 96% of them were for generic drugs. CMS names the drug for 76 of them, across 3 drugs with 11 or more claims each, at $184 in total drug cost. In 2023, CMS named 73 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 69 out of 100 for Dr. Navasartian for performance year 2024, reported as part of a group. Dr. Navasartian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Navasartian, more than 64% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Navasartian in 2019. Dr. Navasartian's most frequent co-author is Stephen S. Burkhart, MD.

CMS Open Payments shows 163 general payments to Dr. Navasartian from 12 drug and device companies from 2017 to 2025. Education make up the largest share, 56% of the total. Arthrex, Inc. paid the most, $23,355.

Dr. Navasartian graduated from Renaissance School of Medicine at Stony Brook University in 2013.

Dr. Navasartian is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.